Main Menu

GH Research - private company seeking to patent a ROA

Started by moonbeam, February 22, 2021, 12:39:15 PM

Previous topic - Next topic


I was surprised to come across this private company doing a clinical study on the use of 5-MeO-DMT for treating treatment-resistant depression.  It looks like they're seeking to patent a certain Route of Administration.  No mention of it being an adjunct to psychotherapy.

GH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress



OMG I was so naive... apparently there's a fair bit of this kind of thing going on.


Yes, unfortunately this sort of thing is happening all over the place.